Looking to 2011. There have been plenty of Top Moments of 2010, but these typical end-of-the-year retrospectives have been short on 2011 predictions. N. Anthony Coles, president and CEO of Onyx Pharmaceuticals, offers his list:
- An escalating legal battle over the constitutionality of President Obama’s healthcare reform legislation.
- Implementation of the pharma tax, which is expected to raise $2.3 billion a year, and will target branded prescription drug sales of more than $5 million to Medicare and other government programs.
- Rethinking biopharma and physician relationships in light of the implementation of the Sunshine Act in 2012.
To read the full, original article click on this link: Reflections, reflections. How about some predictions? (Morning read) « MedCity News
Author:
